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ABSTRACT
WOULD NOT-FOR-CAUSE RANDOMIZED DRUG TESTING REDUCE
THE INCIDENCE OF DRUG MISUSE AMONG CERTIFIED
REGISTERED NURSE ANESTHETISTS?
by Katy Gayle Gavin
December 2015
Healthcare providers have easy access to drugs of various types and strengths,
often times highly addictive drugs, all the while working long hours in high stress
environments. Studies show that anesthesia providers, among other healthcare providers,
are at highest risk for drug misuse. There are numerous ways substance abuse and
addiction among anesthesia providers could be decreased significantly or prevented
completely including, but not limited to, education, routine mental health evaluations,
stress coping through exercise, debriefing sessions, and mentoring. This project focused
on prevention through randomized not-for-cause drug testing. After an exhaustive review
of the literature was performed, implications for practice and suggestions were
summarized in a white paper proposal, which will be presented to key stakeholders to
include state and national governing bodies of the nurse anesthesia profession, anesthesia
providers, students, and residents.
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CHAPTER I
INTRODUCTION
It is estimated that 10% to 20% of nurse anesthetists will experience some sort of
drug misuse during their career, with males practicing six to ten years being at highest
risk (Bell, McDonough, Ellison, & Fitzhugh, 1999). As cited by the American
Association of Nurse Anesthetists (AANA, 2015), the incidence of drug misuse among
anesthesia providers during their life is approximately 10%-17%. Obtaining accuracy of
the frequency of substance abuse among anesthesia providers is a difficult task. This is
because of the complex issues surrounding this topic, including legal issues, patient
safety, and licensure, just to name a few. According to Wright et al. (2012), the extent of
the problem is more than likely larger than what is reported. As a matter of fact,
impairment while at work is probable, considering almost one out of every ten actively
practicing Certified Registered Nurse Anesthetists (CRNAs) misuses a controlled drug
(Bell et al., 1999). It is important to determine the most effective ways in which to
decrease the risk of chemical dependency among anesthesia providers, ultimately
increasing patient safety and improving outcomes, not only for patients, but for
anesthesia providers as well.
Problem Statement
There are many factors that influence the development of substance abuse and
dependency among providers, including genetics, personality, underlying psychiatric
disorders, stress, access to drugs, and attitude, to name a few (Wright et al., 2012). The
high estimate of providers misusing drugs is alarming; therefore, preventative efforts and
early intervention are imperative in decreasing the number of anesthesia providers
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abusing narcotics and other potentially addictive drugs. The impaired provider is not
only at risk for causing medical errors resulting in poor patient outcomes, but also at
increased risk for death due to overdose, either accidental or intentional. “Attempted
suicide or death by suicide or accidental overdose is not an infrequent presentation of
addiction” (Saunders, 2006, p. 638). The overwhelming evidence of misuse among
anesthesia providers, coupled with the devastating outcomes of such, makes it imperative
for a solution to be actively sought.
Purpose of the Project
With the high number of anesthesia providers estimated to be misusing drugs, or
at increased risk for misusing drugs, impairment on the job is likely, and potentially fatal
outcomes for both the provider and/or the patient are plausible. The financial costs
associated with an impaired provider are infinite. A randomized not-for-cause drug
screening may prevent misusing these highly addictive drugs due to the fact that
providers could be randomly tested for drugs at any given time without displaying
symptoms of being impaired and without preparation to adulterate the specimen. This
could potentially help decrease or possibly alleviate the unfortunate risk of drug misuse
among anesthesia professionals, indirectly improving patient safety and outcomes.
According to Wright et al. (2012, p. 126), in 2010, the American Association of Nurse
Anesthetists’ model policy for random drug screening recommended “frequent random
urine drug screening of small numbers of employees.” However, the current position
statement regarding “Substance Misuse and Chemical Dependency” is a “comprehensive
for-cause drug testing program” (AANA, 2015, n.p.). Therefore, the purpose of this
capstone was to develop a white paper proposal for clinical implications of random not-
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for-cause drug screening and suggestions for possible future research. The intention of a
white paper is to promote a solution to a certain problem (The Writing Lab, The OWL at
Purdue, & Purdue University, 2010). In this instance, the problem is impaired anesthesia
providers, and one of the proposed solutions is not-for-cause random drug testing.
Clinical Question
For the clinical question, the population (P) of interest is Certified Registered
Nurse Anesthetists; the intervention (I) suggested is not-for-cause randomized drug
screening; the comparison (C) is a pre-employment drug screening or for-cause screening
if a provider displays symptoms of being impaired; and the outcome (O) is decreasing the
risk of chemical dependency and the misuse of drugs among anesthesia providers. The
PICO question addressed is: Would not-for-cause randomized drug testing reduce the
incidence of drug misuse among Certified Registered Nurse Anesthetists?
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CHAPTER II
REVIEW OF LITERATURE
Background and Significance
The disease of addiction may cause otherwise intelligent and rational individuals
to do the unimaginable, but often times, these individuals are discreet in their actions.
Drug misuse and chemical dependency among anesthesia providers have been an issue
for many years. Railroad workers, airline pilots, and commercial truck drivers are among
the many professionals required by the United States Congress to submit to random drug
testing to reduce the risk to the public. Why then are not anesthesia providers held to the
same standard when their primary responsibility is to do no harm to the patient?
Arguments could be made for a number of reasons, including financial burdens for the
employer, minimal signs and symptoms of impairment among anesthesia providers, and
many more. Unfortunately, abuse among anesthesia providers is often not recognized
until death, or a near-death overdose has occurred (Wright et al., 2012). Because of this
terrifying statistic, it is crucial to develop policies and protocols with regards to drug
testing, education, and prevention of abuse.
So, why is death often times the first sign of chemical dependency among
anesthesia providers? Is this because the potency of the drugs is so severe that one’s life
can be taken quickly? Or is it because the professionals misusing these drugs are so
highly educated and protective of their license, reputation, and financial security, they go
to great lengths to hide the otherwise obvious signs and symptoms of addiction? It is
likely the combination of both of these reasons and more. The anesthesia profession has
increased stressors due to many variables, such as the demands of working long hours,
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often times in critical, intense situations, and frequently, with minimal sleep. Providers
have easy access to powerful drugs, and are at an increased risk of substance abuse due to
numerous factors. As a matter of fact, more than any other group, physicians, nurses, and
other healthcare providers are at higher risk for misusing drugs (Bell et al., 1999). Of
these, anesthesia providers have the highest risk of death due to drug-related causes
(Wright et al., 2012).
There is a multitude of research available which shows that anesthesia providers
are at an increased risk for chemical dependency, along with other healthcare providers,
and workers in non-healthcare professions. This information provides significant
strength to this project. An anticipated weakness of the project is a possible resistance to
implementation of new policy and procedures possibly due to increased estimated costs.
However, many opportunities exist if new policies related to random drug screening are
implemented. If drug misuse among providers is decreased, there could be countless
lives saved, not only providers who could have potentially overdosed, but patients who
could have been under the care of an impaired provider. Financial losses could be
avoided due to potential errors of an impaired provider, and financial gains are possible
through improved work performance. It may prove difficult to successfully implement
preventative measures due to resistance of the stakeholders. Costs may also be a factor
threatening the success of the project due to limited funding for implementation of
preventative programs such as not-for-cause drug testing.
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Anesthesia
In a 2005 study, it was hypothesized that anesthetics which were aerosolized,
causing second-hand exposure to anesthetists, caused sensitization to the provider, and
ultimately increased their risk for addiction (McAuliffe, et al., 2005). Taking into
account the stressors of the profession already put the provider at an increased risk to
misuse drugs, the provider increases that risk even more by simply using drugs necessary
to perform a successful anesthetic in the majority of procedures; therefore, education,
prevention, and early intervention of drug misuse is imperative. As a matter of fact, some
would agree that education regarding chemical dependency should be implemented as
soon as training begins. In one study, a survey of anesthesia program directors found
incidents of substance abuse among anesthesia students, where results included loss of
nursing licensure, termination from the program, and even death (Bozimowski, Groh,
Rouen, & Dosch, 2014).
As referenced by Saunders (2006), a study performed by the Alcohol and Drug
Research Centre in Edinburgh at the request of The Association of Anaesthetists of Great
Britain and Ireland revealed a “lack of awareness of schemes to deal with problems of
alcohol and drug abuse within hospital trusts” (p. 638). In many cases, providers are not
tested for drugs until they are reported by a co-worker for displaying certain signs and
symptoms of impairment. According to the American Association of Nurse Anesthetists
(AANA, 2015), some of the signs and behaviors to look for include, but are not limited
to, isolation and withdrawal from peers, gradual decline in work performance,
consistently signing out more narcotics than colleagues, frequent bathroom breaks, desire
to take extra call, increased difficulty with authority, elaborate excuses, dishonesty over
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trivial/unimportant matters, and patterns of inappropriate drug choices and dosages,
among others.
The AANA (2015) emphasizes knowledge of signs and behaviors of an impaired
provider is vital; however, the AANA also recognizes that identifying impairment in a
colleague is difficult. This may be due to the fact that these changes in behavior may not
be abrupt. According to the AANA, as cited in Luck and Hendrick (2004), these
behavior changes may occur little by little, over the course of months or years, making
them complicated to identify. There are multitudes of ways impaired providers may
conceal their addiction from others. Addicts may alter their charting to show certain
drugs were given, when in fact, another drug was given, or sometimes, to the detriment of
the patient, none were given at all; some addicts may replace their drug of choice with
another liquid, leaving the vial as if it had never been tampered with or accessed at all
(Bryson & Silverstein, 2008). Anita Bertrand, a Certified Registered Nurse Anesthetist
practicing in Houston, stated, “I was absolutely impaired, using narcotics while
working…And no one ever noticed;” she even placed an intravenous port in her ankle for
easier access to administer her drug of choice (Eisler, 2014). Bertrand stated, “There are
so many practitioners working impaired and we have no idea…we’re doing a terrible job
addressing this problem” (Eisler, 2014).
Another example of how anesthesia providers may be misusing drugs and going
undetected is abusing drugs not typically accounted for by the pharmacy, unlike
controlled drugs such as narcotics. For example, in a survey of 126 anesthesia residency
programs, 18% of the departments had documented accounts of the anesthetic drug,
propofol being misused, and seven reports of death due to propofol abuse (Wischmeyer et
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al., 2007). In another survey of members of Anesthetists in Recovery, almost one-third
admitted to injecting themselves with propofol on at least one occasion (Stocks, 2011).
Intravenous drugs are not the only non-controlled drugs of abuse; according to a survey
by Wilson et al. (2008), 22% of respondents reported one or more persons abusing
inhalational anesthetics, with 26% of those resulting in death. According to this same
report, there was no pharmacy accounting of inhalational anesthetics by a majority of the
anesthesia departments (Wilson et al., 2008).
Nursing
The incidence of drug misuse among the nursing profession is profound. Looking
at one example of the severity at the state level puts the issue into perspective. On
average, approximately 300 nurses yearly are disciplined by the Alabama State Board of
Nursing for having substance misuse problems, as cited by Monroe, Vandoren, Smith,
Cole, and Kenaga (2011). One study found that an estimated seventeen thousand nurses
in the United States were identified with substance abuse problems in a one year period
(Monroe, Kenaga, Dietrich, Carter, & Cowan, 2013). This is an overwhelming and
frightening statistic as these individuals are charged with caring for the public.
In 2012, as cited by New (2014), a nurse received a prison sentence because of
her diversion of drugs. This nurse had replaced hydromorphone with normal saline, and
by doing so, the nurse caused twenty-five people to become infected with a blood borne
pathogen (New, 2014). Some of these patients were in critical condition, some required
surgery, and one person lost their life (New, 2014). Ultimately, nurses are threatening the
safety of those they care for as well as themselves when they divert drugs. It is vital for
governing bodies, from the national level to the individual institution, to have strict
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policies and procedures in place to prevent or maximally decrease the incidence of drug
misuse.
Medical Professionals
The disease of addiction is not limited to anesthesia providers and nursing staff.
Fung and Lange (2011)cited references estimating 6-10% of dentists were chemically
dependent. In 2009, an investigation into an outbreak of the hepatitis C virus began in
Colorado (Warner et al., 2015). This investigation would eventually reveal that a
hepatitis C positive surgical technician was taking syringes of fentanyl from unattended
anesthesia carts, self injecting, refilling the same syringe with saline, and then returning
the syringe to the cart (Warner et al., 2015). According to Warner et al. (2015), another
incident involving an outbreak of hepatitis C in New Hampshire identified a traveling
radiology technician as the source.
Hamza and Bryson made a profound statement in their 2012 publication: “Opioidaddicted health care providers are masters of drug diversion. Education does not grant
anybody immunity from developing addiction, and in this population, intelligence can be
used to cleverly circumvent narcotic accountability and drug substitution” (p. 266).
Because of this subtle and manipulative behavior, it is crucial that drug testing protocols
be implemented. In a survey of 1,891 medical physicians, over 300 reported being
directly aware of a physician associate who was under the influence or not competent to
practice medicine (DesRoches et al., 2010). Sixty-seven percent of those with that
knowledge stated that the impaired physician was the one to whom they would otherwise
report (DesRoches et al., 2010. When faced with these types of situations, many do not
report. The top three reasons for not reporting, according to the study by DesRoches et
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al. (2010), were thinking that another person had taken care of it, thinking reporting the
problem wouldn’t make a difference, and apprehension of retaliation. Knowing that
many practitioners recognize signs and symptoms of impairment but still choose not to
act, makes it all the more essential to implement randomized drug testing.
Non-Healthcare Professionals
Chemical dependency and drug abuse are not limited to healthcare professionals.
The United States Congress implemented an act for mandatory testing of transportation
employees with safety sensitive functions after major incidents occurred, such as the
Exxon Valdez oil spill, thus bringing much needed public attention to this serious issue
(Li, Brady, DiMaggio, Baker, & Rebok, 2010). Consider the results of the random
testing performed by the Federal Aviation Administration during 1995-2005. There were
over half a million alcohol tests performed, with 601 alcohol violations and over one
million drug tests performed, with 7,211 drug violations (Li et al., 2010). These were a
small percentage of positives considering the number of individuals tested, but the
consequences of not detecting these individuals could have been catastrophic.
Li et al. (2011) also state general aviation, which consists of non-commercial
flights, account for more than 90% of all flight accidents and deaths. These general
aviation flights are not covered by the mandatory drug-testing programs (Li et al., 2011).
Therefore, one could conclude statistics involving drug related aviation accidents do not
accurately depict the data. Other transportation employees affected by drug-testing
included commercial drivers. They have a significantly higher rate of impairment
compared to aviation. In a 2009 study of over sixty-six thousand fatal multi-vehicle
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crashes, almost 20% of non-motor carrier drivers tested positive for alcohol in a blood
test (Brady et al., 2009).
Drug Testing
According to Eisler (2014), hospitals and other health care facilities rarely
perform random drug testing, and there are no state laws that require it. With this
knowledge, chemically dependent individuals who misuse drugs may feel they are at a
decreased risk of being tested, and ultimately, a decreased risk of being caught misusing.
There are many pros and cons of random not-for-cause testing. One of the pros of a
randomized screen is there would be a decreased risk of a provider cheating the test when
there is no prior knowledge of such a test. According to Cholakis and Bruce (2007), most
workplace drug testing is performed prior to the provider beginning work, and this type
of testing generally uses a traditional urinalysis; knowing this, drug abusers may stop
using detectable drugs in an adequate amount of time before the test, then begin using
again after they pass the test. An Internet search of the phrase beat drug test in July 2015
resulted in over thirteen million hits; cheating drug tests has become a real issue.
Between May 2004 and April 2005, about 10,000 specimens tested in certified labs were
“found to be adulterated, substituted, or invalid” (Bush, 2007, p. 116). This isn’t
surprising considering the availability of products to do such.
There are numerous products available to alter results of drug screens, not only
for urine, but other bodily specimens as well. There are shampoos available for hair
samples, mouthwashes for oral fluid samples, and for blood, there are “whole body
cleansers” (Bush, 2007, p. 116). Because of these products readily available on the
market, random drug screening may be more appropriate in detecting drug abuse.
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Random drug screening may not only help with prevention, it may also benefit those who
have already been chemically dependent. There are improved outcomes of recovery
when random drug screening is performed among recovering physicians, seemingly due
to the repercussions of not passing the drug screen (Fitzsimons, Baker, Lowenstein, &
Zapol, 2008). It is important to monitor these individuals in the recovery process, not
only with random drug screening, but also with routine mental screening. In a study of
health care professionals with substance abuse disorders by Domino et al. (2005), the
presence of a co-existing psychiatric illness significantly increased the likelihood of
relapse. These individuals are at an increased risk for reverting back to drug diversion,
and therefore would benefit greatly from random drug screening.
The financial burdens are more than likely one of the top negative aspects
associated with drug testing, as it can result in significant costs to the employer.
However, random testing can identify individuals who may not necessarily exhibit the
classic signs and symptoms, and may ultimately save lives and dollars. In a study
analyzing over 15,000 households, findings suggested that drug-testing programs
deterred some potential drug-using employees, but may also decrease morale and
discourage productive employees (French, Roebuck, & Alexandre, 2004). Drug testing
programs which deter potential drug users can also come at a cost. To put an exact
number on the cost, of course, is nearly impossible due to the variables and
considerations. In 2006, however, the effectiveness and benefit-cost ratio was analyzed
in a transportation company with a peer-based substance abuse program (Miller,
Zaloshnja, & Spicer). The findings in this particular situation showed an estimated
$1,850 savings per employee in avoided injury costs due to the program. Therefore, in
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this instance, the peer-based program in conjunction with random testing proved to be
cost-effective in the workplace (Miller, Zaloshnja, & Spicer, 2006).
A few variables to consider when it comes to cost-benefit of an impaired
anesthesia provider would be the costs of medications redirected from the patient, the
cost of unfavorable outcomes of a patient if the impaired provider made a medical error,
costs of lost labor from days off of work, and the costs of the drug testing just to name a
few. Bryson and Silverstein (2008) quoted costs from a laboratory in New York state
charging $32.50 to test for fentanyl in a urine sample, and $290 to test for propofol in a
urine sample; the cost for testing hair samples can be over a thousand dollars. However,
with the short half-lives of many commonly abused drugs, hair analysis is often time the
best choice for detecting chronic drug misuse (Kintz, Villain, Dumestre, & Cirimele,
2005). Costs for the employer are not only incurred through testing, however, chemical
dependency costs businesses in other ways. The cost to a business on average is about
$10,000 per drug user due to decreased productivity, missing work with greater than ten
absences, and increased insurance rates (Cholakis & Bruce, 2007). As for healthcare
facilities, the Centers for Medicare and Medicaid Services (2004) can terminate services
if a diversion case involving patient harm leads to Immediate Jeopardy.
According to a report published in 1999 by the Institute of Medicine, operating
rooms were one of the places within a hospital where high error rates were most likely to
occur. This not only resulted in an estimated total national cost between $17 billion and
$29 billion per year, but perhaps more importantly, in the loss of human lives. The
impairment of the anesthesia provider significantly increases the risk for a compromise in
patient safety and error in the operating room (Wright et al., 2012). Of all healthcare
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providers found misusing drugs, anesthesia providers have the highest risk of death due
to drug-related causes (Wright et al., 2012). The costs associated with addicted
anesthesia providers are high for all parties involved, including the provider, the patient,
the employer, the patient’s families, and even colleagues of the impaired provider.
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CHAPTER III
CONCEPTUAL AND THEORETICAL FRAMEWORK
Analysis of the Nursing Process Theory and Capstone Fit
The explanatory theory is a middle-ranged theory designed to build knowledge; it
“identifies how the properties and components relate to one another and accounts for the
functions of the discipline” (Purnell, 2011, p. 526). This theory was utilized to explain
not only the association of risk factors of chemical dependency to the profession of
anesthesia, but how random drug testing may decrease that risk. Furthermore, as a
doctoral prepared anesthesia provider, the intent was to provide knowledge to other
anesthesia providers of the signs and symptoms to look for in an impaired anesthetist in a
collaborative effort to further decrease risks of chemical dependency to anesthetists. I
also provided knowledge of what the literature shows and provided implications of
practice, as well as suggestions for further research, to the key stakeholders in the form of
a white paper analysis.
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CHAPTER IV
METHODOLOGY
Target Outcome
The primary objective of this capstone project was to determine if a not-for-cause
random drug testing protocol would be beneficial in reducing the number of anesthesia
providers who misuse drugs, and/or decrease the risk for those who are not actively
misusing. The target outcome was to develop a white paper/policy proposal and
eventually present to key stakeholders who could ultimately implement a policy change
for drug testing among anesthesia providers. Results of the project are to be presented to
those who could benefit from this knowledge. An exhaustive review of literature was
performed to answer the PICO question, “Would not-for-cause randomized drug testing
reduce the incidence of drug misuse among Certified Registered Nurse Anesthetists?”
Research not only focused on the literature of the target population, but it also observed
the literature related to drug misuse among other healthcare providers and employees in
professions outside of the healthcare industry. Once this data was gathered and analyzed,
a set of best practice guidelines and future research recommendations were established.
In the form of a white paper analysis, these are to be presented to key stakeholders, such
as state and national governing bodies, anesthesia providers, and students, for
consideration.
Population
During the literature review process several populations were studied. The main
population of focus with this capstone project was Certified Registered Nurse
Anesthetists. Other populations studied were professions who affected the general public
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such as nursing, other healthcare providers, and transportation entities. Although the
study results were centered on anesthesia providers, the findings could be potentially
implemented in all areas of healthcare and other professions, given that chemical
dependency is a disease that does not discriminate.
Methods
An extensive and thorough literature review was conducted. Literature was
obtained from the following databases: Cumulative Index to Nursing and Allied Health
Literature (CINAHL), American Association of Nurse Anesthetists online research,
Medline, Google Scholar, Academic Search Premier, and PubMed. After the results were
compiled, a white paper proposal of best practice guidelines for drug testing for
prevention of chemical dependency was developed. These guidelines can be utilized by
stakeholders, including state and national governing bodies for nurse anesthetists,
anesthesia providers, students, and the families of providers.
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CHAPTER V
IMPLICATIONS
Anesthesia providers do not have a set of best practice guidelines established with
regards to not-for-cause random drug testing. Evidence shows anesthesia providers are at
the highest risk for chemical dependency than any other healthcare provider, and on-thejob impairment could have devastating and fatal outcomes for both the patient and
provider. Established guidelines for random drug testing have the potential to
significantly decrease the risk for addiction as well as decrease the number of on-the-job
impaired providers and improve patient outcomes. This research could also set the
foundation for future research related to drug testing. This, in turn, could ultimately
improve patient safety and patient outcomes, decrease costs, and save lives. If
successful, these policies could potentially be implemented into other areas of health care
as well, including physicians, nursing, radiology, and other ancillary staff. After
thorough review of the literature, a white paper analysis was developed for presentation
to stakeholders including state and national governing bodies, anesthesia providers,
students, residents, and families of providers.
Evidence-based practice will be used to facilitate change. For this capstone
project, Stetler’s model of Evidence Based Practice was the applied model. This model
involves five steps which include preparation, validation, comparative
evaluation/decision making, translation/application, and evaluation (Ciliska et al., 2011).
The first phase consisted of recognizing and establishing a superior need, which in this
case was the prevalence of impaired anesthesia providers. The next phase involved an
exhaustive review of the literature and assembling evidence related to the need. After
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that, the data was evaluated, and key points were noted and determined to be essential in
providing evidence to implement change. Subsequently, the evidence was compiled and
a white paper analysis was developed. Once this analysis is submitted to key
stakeholders mentioned, if change is implemented, an evaluation of the recommendations
will take place.
Barriers
There could potentially be several barriers faced when attempting to present this
capstone project to key stakeholders. Resistance to change policies may be a factor.
Another possible issue would be the perceived costs of implementing programs for
randomized drug testing. There may also be arguments against random drug testing due
to the potential of unfair testing procedures and protocols. Through support of the
literature and cost benefit analysis, prospective obstacles may be avoided when presented
to the stakeholders, which will include state and national governing bodies, anesthesia
providers, and students.
Implications for Practice
If these guidelines and recommendations are implemented, and demonstrate
success in decreasing addiction risks, identifying impaired anesthetists, and preventing
addiction, then it is hopeful that the future generation of anesthesia providers will
experience a decreased incidence of drug misuse. Furthermore, with the combination of
education and drug testing data, which would be obtained from implementation in the
anesthesia profession, similar drug testing programs among other disciplines of nursing
and healthcare could develop. The process of random drug testing, as we know it could
potentially change. The cost benefits of different types of testing for certain drugs could

20
be researched further. Urine sampling may no longer be the norm, and oral fluid or hair
samples may be the new samples of choice with randomized drug screening for
healthcare providers and other disciplines. Further research may also be implemented as
a result of this white paper proposal, including further studies related to the risk factors
associated with chemical dependency, implementation of programs counseling high-risk
individuals, addiction education during anesthesia school, and randomized drug testing
during school just to name a few. The potential changes could significantly improve
work performance, decrease medical errors related to impaired providers, and improve
patient safety and outcomes in all areas of healthcare.
There are endless possibilities for future implications for practice and further
research. Bryson and Silverstein cited a study performed in 1990 of a report of 180 cases
of substance abuse among anesthesiology residents, where thirteen died as a result of
relapse (2009). Individuals who have a prior history of abuse have an increased risk of
relapse and the risk increases further with each relapse (Domino et al, 2005). According
to a study by Wright et al. (2014), random drug testing was noted to be a “definite
deterrent to using” (p. 72). Perhaps, randomized drug testing for those in recovery should
be more frequent than what is currently required.
Other possible implications to consider would be policy changes at various levels.
According to the Re-Entry Recommendations and Resources of the American
Association of Nurse Anesthetists (AANA, 2015), a monitoring program of a minimum
of five years is recommended as part of recovery. One suggestion based on the current
literature would be for mandatory randomized drug testing for the remainder of the
individual’s career in anesthesia, and on a more frequent basis than the non-recovering
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provider. Another recommendation to consider would be permanently revoking licensure
if individuals are caught misusing drugs while in recovery. This would alleviate the risk
of relapse, and perhaps even death of the provider.
Other policy changes may include the pharmacy department protocols at the
institutional level. One study suggests using an analysis of unusual drug transactions to
detect diversion of drugs (Epstein, Gratch, & Grunwald, 2007). Other considerations are
having policies in place to handle discrepancies, validating and identifying controlled
medications returned to pharmacy, and frequently auditing charts. One way of validating
and identifying medications is through a refractometer. Refractometers are a reasonably
priced and practical technique of drug diversion recognition which can be done on-site
with instant results (O’Neal, Bass, & Siegel, 2007). Depending on the institution size and
staff, policy implementations may differ, but it is critical to have some form of drug
diversion policy in place to reduce the incidence of misuse among providers.
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CHAPTER VI
FULFILLMENT OF THE EIGHT ESSENTIALS OF THE DOCTORAL EDUCATION
FOR ADVANCED NURSING PRACTICE
The DNP Essentials Encompassed
Essential I. Scientific Underpinnings for Practice (Chism, 2013)
Essential one was met by identifying successful ways to decrease risks of
chemical dependence encountered by nurse anesthesia providers though drug testing
strategies. This project also met this essential by encompassing sciences of therapeutics,
psychosocial sciences, and human biology; it focused on how providers interact with
their environment in normal life situations and in critical events (AACN, 20006).
Essential II. Organizational and Systems Leadership for Quality Improvement and
Systems Thinking (Chism, 2013)
According to the American Association of the Colleges of Nursing (AACN),
Doctorate of Nursing Practice (DNP) graduates must be adept in quality improvement
practices and in establishing and maintaining changes, not only at the institutional level,
but at the policy level as well (2006). Essential two focused on quality improvement and
systems thinking by decreasing the risk for chemical dependency, by providing specific
drug testing policy recommendations, and ultimately improving patient outcomes.
Essential III. Clinical Scholarship and Analytical Methods for Evidence-Based Practice
(Chism, 2013)
Essential three was met through an integrated literature review and analysis of
evidence-based guidelines which helped to establish a white paper proposal for a best
practice policy change. By incorporating knowledge gained from other disciplines
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regarding chemical dependency, connections were made, and meaning was given to a
series of isolated data and facts, which might not have been connected otherwise. This
further advanced the understanding of drug testing policies among the anesthesia
profession (AACN, 2006).
Essential IV. Information Systems/Technology and Patient Care Technology for the
Improvement and Transformation of Health Care (Chism, 2013)
Information systems and technology was utilized by accessing databases to gather
research to complete the literature review.
Essential V. Health Care Policy for Advocacy in Health Care (Chism, 2013)
Essential five was addressed through advocating for wellness of the healthcare
providers, thus, ultimately improving patient safety and outcomes as a result. In
addition, by educating stakeholders regarding patient outcomes and potential policy
changes, this essential was met (AACN, 2006).
Essential VI. Interprofessional Collaboration for Improving Patient and Population
Health Outcomes (Chism, 2013)
Collaborating with other healthcare providers through debriefing and educating
them on the signs and symptoms of impaired colleagues, there is a potential to ultimately
improve patient outcomes by decreasing the risk of impaired providers. Through
effective communication and in developing guidelines regarding random drug testing,
essential VI was addressed (AACN, 2006).
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Essential VII. Clinical Prevention and Population Health for Improving the Nation’s
Health (Chism, 2013)
The AACN cites Allen, et al., stating “clinical prevention is defined as health
promotion and risk reduction/illness prevention for individuals and families” (2006). By
providing guidelines for drug testing and recommendations for preventing the risk for
chemical dependency, essential seven was fulfilled.
Essential VIII. Advanced Nursing Practice (Chism, 2013)
According to the AACN, DNP graduates should base their practice on the
application of multiple sciences and should exhibit distinguished assessment skills
(2006). This essential was met due to the fact that the project covers a multitude of
sciences, including psychosocial, behavioral, cultural, economic, and nursing sciences.
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APPENDIX B
LITERATURE REVIEW TABLE

Author/
Date
Bell, D. M.,
McDonough, J.,
Ellison, J.S., &
Fitzhugh, E.C.
(1999)

Study Type

Sample

Methodology

Quantitative

n=1709 actively
practicing CRNAs

Mailed surveys to
AANA members; Chisquare test

Bozimowski, G.,
Groh, C., Rouen,
P., & Dosch, M.
(2014)

Cross-sectional
retrospective study

n=47 program directors
n=23 of the 47 with
complete data

Conclusions

Addiction education
should be mandatory in
anesthesia schools; most
CRNAs feel their
colleagues who
successfully complete
rehab should be permitted
to re-enter the profession;
however, after a relapse,
most believe re-entry
should be denied.
Electronic survey mailed Substance abuse among
to program directors
SRNAs is of concern;
asking for current data future research would be
and data within the
useful. Some limitations,
previous five years
include limited analysis
due to descriptive data;
response rate of 21.7%,
and possible missing,
undocumented, or
overlooked incidents of
substance abuse.
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Brady, J.E., Baker,
S.P., DiMaggio,
C., McCarthy,
M.L., …, & Li, G.
(2009)

Quasi-experimental
design

n=66,138 crashes

Study involved pre- and
post-implementation
time periods of
mandatory alcohol
testing programs
including motor carrier
& non-motor carrier
drivers

Results indicate
implementation of
mandatory alcohol testing
programs associated with
23% decrease in alcohol
involvement in deadly
crashes by motor carrier
drivers.

DesRoches, C.M., Quantitative
Sowmya, R.R.,
Fromson, J.A.,
Birnbaum, R.J.,
Iezzoni, L., Vogeli,
C., & Campbell,
E.G. (2010)

n=1891

Survey of physicians to
determine experiences,
beliefs, and readiness to
report colleagues who
were under the influence
or incompetent to
practice

More than half of
respondents indicated they
agreed with need to report,
but most who had
knowledge of impaired
colleagues did not report
for various reasons.

Domino, Hornbein, Retrospective cohort
Polissar, Renner,
Johnson, …, &
Hankes
( 2005)

n=292 chemically
dependent health care
professionals

Information retrieved
from database of
treatment facility over a
ten year period

Risk of relapse with
substance use increased in
major opioid use, a coexisting psychiatric
illness, or family history
of substance use disorder.
Presence of more than 1
risk factor & previous
relapse increased chances
of relapse further.
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Epstein, R.H.,
Gratch, D.M., &
Grunwald, Z.
(2007)

Data analysis and
record audit

n=2 cases where diversion
was known, using data
mining approach, trends
were identified

Graphical approach used
to find outliers, &
manual audits of
transactions assessed
drug diversion

Kintz, P., Villain,
M., Dumestre, V.,
& Cirimele, V.
(2005)

Case Control

n=4 cases of
anesthesiologists addicted
to fentanyl derivatives

Requested testing for
anesthesia agents in four
legal cases, hair samples
were taken. Three cases
were suspected of
addiction, the fourth was
post-mortem.

Li, G., Baker, S.P.,
Zhao, Q., Brady,
J.E., Lang, B.H.,
…, & DiMaggio,
C. (2011

Retrospective ten
year study

n=4977 post-accident
drug tests
n=1,129,022 random drug
tests

Case-control analysis
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Identifying unusual drug
transactions (frequent
transactions on patients
after surgery or obtaining
drugs off site of
procedure) using
automated drug dispensing
machines is useful in drug
diversion detection
Usually, blood and/or
urine collected at
inadequate times & not
useful to document
impairment; hair testing
should be used as
complement to increase
window of drug detection.
Collection of the sample is
non-invasive, can be done
under close supervision, &
storage at room
temperature.
Aviation employees much
less likely to use illicit
drugs than other
transportation modes &
the general workforce.
However, study limited to
employees of major
airlines, commuter air
carriers, & air taxis.

Li, G., Brady, J.,
DiMaggio, C.,
Baker, S., &
Rebok, G. (2010).

Retrospective
ten year study

n=649,796 random
alcohol tests
n=1,129,922 random
drug tests
n=2284 for-cause alcohol
tests
n=2015 for-cause drug
tests

Monroe, T.B.,
Kenaga, H.,
Dietrich, M.S.,
Carter, M.A., &
Cowan, R. (2013)

Qualitative analysis

n=59 member boards
n=128 nurses per board

Positive Predictive
Values

More difficult to detect a
person under the influence
of illicit drugs than a
person under the influence
of alcohol based on
physical appearance, body
odor, behavior, & job
performance. Limited
accuracy of suspected
alcohol & drug violations
is due in part to low
prevalence of alcohol &
drug use in aviation
employees.
Modified balanced
Prevalence of nurses with
stratified sampling
recognized substance use
technique of a survey of problems= 17,085.
regulatory boards
Prevalence of nurses
disciplinary monitoring enrolled in disciplinary
programs
monitoring programs=
12,060. Limitations of
convenience samples
include recruitment bias &
limited generalization.
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Warner, A.E.,
Schaefer, M.K.,
Patel, P.R.,
Drobeniuc, J., Xia,
G.,…, Thompson,
N.D. (2015)

Patients were
identified through
health records at the
facilities where the
tech was employed,
and were contacted
with a letter
informing them of
their potential
exposure to hepatitis
C

n=5970 patients were
identified who could have
possibly been exposed

Pairwise genetic
distances of nucleotide
quasi-species sequences
were estimated with the
DNADIST program in
the PHYLIP package.
Differences in the
distributions of the
HVR1 genetic distances
were compared using the
ANOVA program.

18 confirmed cases of
hepatitis C transmission
due to diversion of
surgical technician. The
technician was sentenced
to 30 years in prison.

Wilson, J.E.,
Kiselanova, N.,
Stevens, Q., Lutz,
R., Mandler, T.,
Tran, Z.V., &
Wischmeyer, P.E.

Quantitative study

n=106 surveys completed
from anesthesia
departments

Anesthesia department
chairs responded to
online surveys.

22% of anesthesia
departments responding to
surveys reported abusing
inhalational anesthetics.
26% found misusing had
fatal outcomes.
Weaknesses: uncertain
recall of incidences
including inhaled
anesthetics, departments
that did not respond to
survey may have had
incidences of misuse, &
respondents may not have
included cases occurring
before they arrived to
department.
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Wischmeyer, P.E.,
Johnson, B.R.,
Wilson, J.E.,
Dingmann, C.,
Bachman, H.M.,
…, Henthorn, T.K.
(2007).

Descriptive

Wright, E.L.,
McGuinness, T.,
Schumacher, J.E.,
Zwerling, A., &
Moneyham, L.D.
(2014)

Qualitative Inquiry

n=93 anesthesia program
departments

Descriptive analysis of
emailed surveys

Took into account
propofol abuse among all
anesthesia personnel
within the departments
including attendings,
residents, and CRNAs.
Data may not be accurate
for several reasons
including propofol not
being routinely tested in
urine drug screens, and
many case reports
discovered propofol abuse
only after death or when
the individual was found
unconscious.
n= 6
Participants were
All participants agreed
nurse anesthetists who had recruited through online continual involvement in a
experienced anesthetic
advertising; data were
Twelve-Step program was
opioid dependency,
collected through
vital to their recovery.
undergone treatment, dealt semistructured
The need for trigger
with regulatory sanctions
individual telephone
management was also an
against their license, could interviews
important factor. All
not practice for at least 8
participants agreed
months, and successfully
random urine drug
returned to anesthesia
screening was a deterrent
practice
to using.
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